Skip to Content

MYLAN 6727 MYLAN 6727 (Zonisamide 100 mg)

Pill imprint MYLAN 6727 MYLAN 6727 has been identified as Zonisamide 100 mg.

Zonisamide is used in the treatment of migraine prevention; seizures; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Zonisamide 100 mg MYLAN 6727 MYLAN 6727
Zonisamide 100 mg MYLAN 6727 MYLAN 6727 Front
Zonisamide 100 mg MYLAN 6727 MYLAN 6727 Back
Zonisamide 100 mg MYLAN 6727 MYLAN 6727
MYLAN 6727 MYLAN 6727
100 mg
Purple / Blue
18.00 mm
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
ferrosoferric oxide
silicon dioxide
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
microcrystalline cellulose
propylene glycol
sodium lauryl sulfate
titanium dioxide
FD&C Red No. 3
magnesium stearate

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0768 UDL Laboratories Inc
16590-0539 Stat RX USA LLC (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.